首页|子宫内膜透明细胞癌6例

子宫内膜透明细胞癌6例

扫码查看
目的:子宫内膜透明细胞癌(endometrium clear cell carcinoma,ECCC)少见,易误诊、漏诊.本研究旨在探究其临床病理学特征,以提高临床诊断率.方法:回顾性分析6例ECCC患者的临床病理学特征,行免疫组织化学染色,并复习相关文献.结果:患者均为女性,年龄52~81岁,因绝经后异常阴道流血入院.B超提示宫腔异常回声,占位可能.6例镜下可见肿瘤细胞呈透明、嗜酸性、靴钉样改变,可见乳头状、囊管状、实性结构,乳头轴心硬化性改变,细胞异型不明显,部分区域见坏死;1例合并子宫内膜样癌;3例癌组织侵犯肌层(2例侵犯肌层<1/2层、1例侵犯肌层>1/2层),左、右侧盆腔淋巴结未见癌转移.免疫表型:细胞角蛋白7(cytokeratin 7,CK7)、Napsin A、肝细胞核因子1β(hepatocyte nuclear factor 1β,HNF1β)、P504S、配对盒基因8(paired box gene 8,PAX8)阳性;错配修复蛋白MLH1、MSH2、MSH6、PMS2均阳性;P16、波形蛋白(vimentin)阳性或部分阳性;4例P53为部分不均阳性(野生型),2例P53弥漫强阳性(突变型);雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)、白细胞分化抗原10(cluster of differentiation 10,CD10)、雄激素受体(androgen receptor,AR)、肾母细胞瘤基因1(Wilms'tumor gene 1,WT-1)阴性;Ki-67增殖指数为30%~80%.4例行全子宫+双侧附件切除(其中3例并行盆腔淋巴结清扫),2例仅行刮宫处理.随访至2024年5月,1例离世,余均健在.结论:ECCC是一种相对少见的癌,主要见于绝经后女性,可以以单纯的透明细胞癌或者与其他类型的癌混合出现,组织学形态多样且预后不良,需借助免疫组织化学辅助诊断及鉴别诊断.
Endometrium clear cell carcinoma:Six cases
Objective:Endometrium clear cell carcinoma(ECCC)is rare and prone to misdiagnosis or missed diagnosis.This study aims to explore its clinicopathological characteristics to improve diagnostic accuracy.Methods:A retrospective analysis of the clinicopathological features of 6 ECCC cases was conducted,including immunohistochemical staining and a review of relevant literature.Results:All patients were female,aged 52-81 years,presenting with postmenopausal abnormal vaginal bleeding.Ultrasound revealed abnormal intrauterine echoes,suggesting a possible mass.Microscopically,tumor cells exhibited clear,eosinophilic,or hobnail-like morphology with papillary,tubular-cystic,and solid structures,and papillary cores showing sclerosis.Cellular atypia was mild,with necrosis observed in some areas;one case was combined with endometrioid carcinoma.Tumor invasion of the myometrium was found in 3 cases(2 cases with<1/2 myometrial involvement and 1 case with>1/2).No lymph node metastases were detected in the left and right pelvic lymph nodes.Immunophenotype:Tumor cells were positive for cytokeratin 7(CK7),Napsin A,hepatocyte nuclear factor 1β(HNF1β),P504S,and paired box gene 8(PAX8).Mismatch repair proteins,MLH1,MSH2,MSH6,and PMS2 were positive.P16 and vimentin were positive or partially positive.Four cases showed partially heterogeneous P53 positive(wild type),and 2 cases showed diffuse strong P53 positive(mutant type).Estrogen receptor(ER),progesterone receptor(PR),cluster of differentiation 10(CD10),androgen receptor(AR),and Wilms'tumor gene 1(WT-1)were negative.The Ki-67 proliferation index ranged from 30%to 80%.Four cases underwent total hysterectomy with bilateral adnexectomy(3 with pelvic lymphadenectomy),and 2 underwent curettage only.Followed-up to May 2024,1 patient had died,while the others were alive.Conclusion:ECCC is a relatively rare carcinoma,primarily occurring in postmenopausal women.It can present as pure clear cell carcinoma or mixed with other carcinoma types.Its histological patterns are diverse,and its prognosis is poor.Immunohistochemistry is essential for diagnosis and differential diagnosis.

clear cell carcinomahistological changesimmunohistochemistryprognosis

李明、张帆

展开 >

亳州市人民医院病理科,安徽亳州 236800

皖南医学院弋矶山医院病理科,安徽 芜湖 241000

透明细胞癌 组织学改变 免疫组织化学 预后

2024

临床与病理杂志
中南大学

临床与病理杂志

CSTPCD
影响因子:0.559
ISSN:1673-2588
年,卷(期):2024.44(8)